Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Evofem Biosciences, Inc.
| Metric | Evofem Biosciences, Inc. EVFMHealthcare |
|---|---|
| Quality Score | 48 / 100 |
| Revenue (latest) | $20M |
| Net income (latest) | $391,000 |
| Operating margin | 16.7% |
| Net margin | 1.9% |
| Return on equity | −0.5% |
| Return on assets | 1.9% |
| Return on capital (ROCE) | — |
| Debt / equity | — |
| Revenue growth (YoY) | 4.2% |
| Altman Z″ (distress) | -166.55 |
| Accruals / assets | 11.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.